NCT07722156Not yet recruiting
The Effect of Channa Striata and Curcuma Supplementation on Nutritional Status, Interleukin-6 Levels, and Quality of Life in Patients With Breast Cancer.
Source: ClinicalTrials.gov · Last updated 23 Jul 2026
Brief summary (registry, in English)
Breast cancer is frequently accompanied by chronic inflammation, malnutrition, and reduced quality of life, all of which may compromise treatment response and clinical outcomes. Nutritional interventions with immunomodulatory and anti-inflammatory properties have the potential to improve these conditions. Channa striata is rich in high-quality protein, albumin, and essential amino acids that support nutritional recovery and tissue repair, while Curcuma contains curcumin, a bioactive compound with well-established anti-inflammatory and antioxidant effects. This study aims to evaluate the effect of combined Channa striata and Curcuma supplementation on nutritional status, serum interleukin-6 (IL-6) levels, and quality of life in patients with breast cancer undergoing treatment. The findings are expected to provide evidence for the use of this nutritional supplementation as a complementary strategy to improve clinical outcomes, reduce systemic inflammation, and enhance the overall well-being of breast cancer patients.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 76 (estimated)
- First submitted
- 15 Jul 2026
- Start date
- 1 Aug 2026
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- DINA KEUMALA SARI
- Diseases
- Childhood cancers
- NCT number
- NCT07722156
What you commit to
- Study type: Interventional
- Planned participants: 76
- From 1 Aug 2026 to the primary completion date, 31 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients receiving other protein or amino acid supplements during the study period.
Other illness
- Patients with chronic kidney disease, renal failure, or kidney infection.
Lab values
- Patients with a known allergy to fish or Channa striata (snakehead fish) albumin-derived products.
Other
- Patients who were non-compliant or discontinued the intervention before completion of the study.
Who the study is looking for
- Female patients with breast cancer aged ≥18 years who were undergoing chemotherapy.
- Patients with a body mass index (BMI) of 18-29 kg/m².
- Patients currently receiving chemotherapy for breast cancer.
- Patients with serum albumin levels of 2.0-3.5 g/dL.
- Patients who were able to consume oral food and were willing to participate in the study by providing written informed consent.
Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Nutrition Department Coordinator of this site? Confirm its status | Medan | Indonesia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.